EDGAR Verified
Primary Source · SEC.gov

CCA Longevity Fund V (US) LLC

CIK 0001996278Fund Vehicle2024 vintage506(b), 3(c)

Raised

Pre-open

Investors

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

CCA Longevity Fund V (US) LLC is a Delaware pooled investment fund filed under Rule 506(b) and 3(c) exemptions. This is an amended filing with pre-open status; no capital raised, investor count, or minimum investment has been disclosed. William Corry is listed as director.

This longevity biotech fund utilizes the 506(b) private placement exemption typical for institutional venture funds, allowing general solicitation restrictions in exchange for flexibility on investor accreditation verification. The pre-open amended filing pattern suggests organizational or structural updates prior to formal capital deployment, common in the venture fund lifecycle.

Data Flags

generalAmended filing in pre-open status with no disclosed capital or investor metrics; suggests structural or administrative revision before formal fundraising commencement
related_personsSingle director listed (William Corry) with no other related persons disclosed, which is minimal for typical fund governance structures

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001996278
Entity NameCCA Longevity Fund V (US) LLC
Exemption506(b), 3(c)
First Sale Date
Filing DateOctober 11, 2024
Accession Number0001996278-24-000001
Total Amount Sold
Total Investors
Minimum Investment$0 (no stated minimum)
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

William Corry

Director · Vero Beach, FL

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.